三鑫医疗收盘上涨14.24%，滚动市盈率23.77倍，总市值56.16亿元

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Sanxin Medical, which closed at 10.75 yuan, up 14.24%, with a rolling PE ratio of 23.77, marking a new low in 738 days, and a total market capitalization of 5.616 billion yuan [1] - The average PE ratio for the medical device industry is 57.51, with a median of 41.25, placing Sanxin Medical at the 49th position in the industry ranking [1] - Sanxin Medical's main business includes research, manufacturing, sales, and service of medical devices, with key products in blood purification, drug delivery devices, and thoracic surgery [1] Group 2 - In the latest performance report for the first half of 2025, Sanxin Medical achieved operating revenue of 761 million yuan, a year-on-year increase of 10.83%, and a net profit of 115 million yuan, up 8.35%, with a gross profit margin of 34.97% [1] - The company has received several honors, including recognition as an "Excellent Intelligent Manufacturing Scenario" by the Ministry of Industry and Information Technology and as a "Benchmark Enterprise in Intelligent Manufacturing" in Jiangxi Province [1] - The financial data indicates that Sanxin Medical's PE (TTM) is 23.77, while the industry average is 57.51, and the industry median is 41.25 [2]